Natco Pharma Ltd. - Research Center
524816 NATCOPHARM Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Sales | 1,236.90 | 964.80 | 625.30 | 930.50 | 1,048.30 |
| Operating profit | 763.00 | 452.70 | 238.30 | 442.30 | 503.70 |
| Interest | 4.40 | 4.50 | 3.80 | 3.00 | 3.20 |
| Gross profit | 798.40 | 484.10 | 264.00 | 464.00 | 515.10 |
| EPS (Rs) | 35.55 | 19.50 | 10.73 | 20.12 | 22.64 |
Quarterly
results in details
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Other income | 39.80 | 35.90 | 29.50 | 24.70 | 14.60 |
| Stock adjustment | -13.40 | -29.70 | 7.40 | 7.50 | 32.00 |
| Raw material | 151.30 | 127.60 | 92.20 | 166.60 | 136.10 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 120.20 | 125.00 | 103.90 | 106.80 | 119.20 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 215.80 | 289.20 | 183.50 | 207.30 | 257.30 |
| Provisions made | - | - | - | - | - |
| Depreciation | 40.40 | 51.60 | 40.40 | 40.00 | 39.90 |
| Taxation | 121.70 | 83.40 | 31.60 | 63.80 | 69.90 |
| Net profit / loss | 636.30 | 349.10 | 192.00 | 360.20 | 405.30 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 35.80 | 35.80 | 35.80 | 35.80 | 35.80 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 61.69 | 46.92 | 38.11 | 47.53 | 48.05 |
| GPM (%) | 62.54 | 48.38 | 40.32 | 48.58 | 48.46 |
| NPM (%) | 49.84 | 34.89 | 29.32 | 37.71 | 38.13 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis